Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ML 315 is a selective Clk and DYRK inhibitor with potential anticancer activity for the study of neurological disorders.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 98.00 | |
10 mg | In stock | $ 163.00 | |
25 mg | In stock | $ 347.00 | |
50 mg | In stock | $ 569.00 | |
100 mg | In stock | $ 813.00 | |
500 mg | In stock | $ 1,630.00 |
Description | ML 315 is a selective Clk and DYRK inhibitor with potential anticancer activity for the study of neurological disorders. |
Molecular Weight | 374.22 |
Formula | C18H13Cl2N3O2 |
CAS No. | 1440251-53-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ML 315 1440251-53-5 Cell Cycle/Checkpoint Tyrosine Kinase/Adaptors CDK DYRK ML315 Hydrochloride ML-315 Hydrochloride inhibitor inhibit